BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

AMPEL BIOSOLUTIONS, LLC — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

AMPEL BIOSOLUTIONS, LLC

via AMERICAN DEFENSE INTERNATIONAL

1st Quarter (Jan 1 - Mar 31) · 2024Posted Apr 17, 2024Filing document ↗LDA record ↗

Income$5Kfee reported

Client

Name: AMPEL BIOSOLUTIONS, LLC
Description: Health management
Location: Virginia · United States of America

Registrant

Firm: AMERICAN DEFENSE INTERNATIONAL
Description: Lobbying and consulting firm.
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Defense
Issues relating to clinical trials management.
LobbyistsVAN HIPP jr
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.